[ad_1]
Startups are challenging market leader Illumina Inc. in the race to lower the cost of DNA sequencing and expand use of the technology throughout research and medicine.
DNA sequencing lets scientists read the individual bases, or letters, of genetic code. It fuels biological research and the hunt for new medicines and diagnostics.
[ad_2]
